Figure 4

Serum tumor markers (NSE, Ca 15–3, CEA, PSA, Ca 12–5, Ca 19–9) of 14 patients were analyzed before and after the virus administration. Patient codes and specific tumor marker are indicated in each panel. Data are presented as proportional change (%) of marker from pretreatment (day 0) value.